Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 16/20 | 1.00 |
| ▸ | AHR | P35869 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | GPR3 | P46089 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | PLK4 | O00444 | 1/20 | 0.48 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.48 |
| ▸ | AURKA | O14965 | 1/20 | 0.48 |
| ▸ | CHUK | O15111 | 1/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.48 |
| ▸ | JAK2 | O60674 | 1/20 | 0.48 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.48 |
| ▸ | PAK4 | O96013 | 1/20 | 0.48 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.48 |
| ▸ | ABL1 | P00519 | 1/20 | 0.48 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.48 |
| ▸ | PRKCG | P05129 | 1/20 | 0.48 |
| ▸ | INSR | P06213 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362207 | 1.00 | KIF11 (1.00) | KIF11AHRALDH1A1GPR3HSD17B10 | |
| SCHEMBL2606005 | 0.90 | KIF11 (0.81) | KIF11ALDH1A1HSD17B10 | |
| SCHEMBL29539315 | 0.90 | KIF11 (0.81) | KIF11ALDH1A1HSD17B10 | |
| SCHEMBL29588087 | 0.89 | KIF11 (1.00) | KIF11AHRALDH1A1GPR3HSD17B10 | |
| Carbazole SCHEMBL28794196 | 0.89 | KIF11 (1.00) | KIF11AHRALDH1A1GPR3HSD17B10 | |
| SCHEMBL29363588 | 0.89 | KIF11 (1.00) | KIF11AHRALDH1A1GPR3HSD17B10 | |
| SCHEMBL10090582 | 0.89 | KIF11 (1.00) | KIF11AHRALDH1A1GPR3HSD17B10 | |
| Bromide SCHEMBL30567841 | 0.88 | KIF11 (0.78) | KIF11ALDH1A1HSD17B10 | |
| Ammonia Solution, Strong SCHEMBL28293743 | 0.87 | KIF11 (0.96) | KIF11AHRALDH1A1GPR3HSD17B10 | |
| SCHEMBL23327761 | 0.86 | KIF11 (0.76) | KIF11AHRCHUK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107935913-A | Carbazole compound and its synthetic method and application | 华东师范大学 | 2018-04-20 | — | — | CN | claimed |
| EP-3728239-B1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-05-20 | — | — | EP | disclosed |
| US-12635331-B2 | Organic electroluminescent device emitting light | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-3670507-B1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-05-06 | — | — | EP | disclosed |
| EP-4709112-A2 | ORGANIC ELECTROLUMINESCENT DEVICE | Samsung Display Co., Ltd. (KR) | 2026-03-11 | — | — | EP | disclosed |
| EP-4709113-A2 | ORGANIC ELECTROLUMINESCENT DEVICE | Samsung Display Co., Ltd. (KR) | 2026-03-11 | — | — | EP | disclosed |
| EP-4214766-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2026-03-04 | — | — | EP | disclosed |
| EP-4214779-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2026-02-18 | — | — | EP | disclosed |
| EP-4692276-A2 | ORGANIC MOLECULES WITH A TRIFLUOROMETHYL-BIPHENYL CORE FOR USE IN OPTOELECTRONIC DEVICES | Samsung Display Co., Ltd. (KR) | 2026-02-11 | — | — | EP | disclosed |
| EP-3724181-B1 | ORGANIC MOLECULES WITH A TRIFLUOROMETHYL-BIPHENYL CORE FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2026-01-28 | — | — | EP | disclosed |
| US-7939666-B2 | Enzyme inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2011-05-10 | — | — | US | disclosed |
| US-7932246-B2 | Histone deacetylase inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2011-04-26 | — | — | US | disclosed |
| US-20100317678-A1 | HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | CHROMA THERAPEUTICS LTD. (GB) | 2010-12-16 | — | — | US | disclosed |
| US-20100244676-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100244676-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100152155-A1 | Histone Deacetylase Inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2010-06-17 | — | — | US | disclosed |
| US-20090298924-A1 | HYDROXAMIC ACID DERIVATIVES AS INHIBITORS OF HDAC ENZYMATIC ACTIVITY | CHROMA THERAPEUTICS LTD (GB) | 2009-12-03 | — | — | US | disclosed |
| US-20090298924-A1 | HYDROXAMIC ACID DERIVATIVES AS INHIBITORS OF HDAC ENZYMATIC ACTIVITY | CHROMA THERAPEUTICS LTD (GB) | 2009-12-03 | — | — | US | disclosed |
| US-20090291978-A1 | Enzyme Inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2009-11-26 | — | — | US | disclosed |
| US-20090291978-A1 | Enzyme Inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317678-A1 | HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | H1-2, HDAC1, H1-0 | KIF11 3276/4885AHR 777/4885ALDH1A1 724/4885 |
| US-20090298924-A1 | HYDROXAMIC ACID DERIVATIVES AS INHIBITORS OF HDAC ENZYMATIC ACTIVITY | HDAC1, HDAC3, HAT1 | KIF11 4537/4885AHR 138/4885ALDH1A1 348/4885 |
| US-12635331-B2 | Organic electroluminescent device emitting light | HBS1L, ETFB, EPHB3 | KIF11 2602/4885AHR 1989/4885ALDH1A1 1485/4885 |
| US-20090291978-A1 | Enzyme Inhibitors | HAT1, NR2E1, NR2C2 | KIF11 4724/4885AHR 813/4885ALDH1A1 1343/4885 |
| US-20100152155-A1 | Histone Deacetylase Inhibitors | HDAC1, HDAC2, HDAC11 | KIF11 1861/4885AHR 1544/4885ALDH1A1 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.